Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Deflazacort in Impacted Lower Third Molar Surgery
NCT04365088Phase 4Unknown
- Sponsor
- Van Yuzuncu Yil University
- Start
- Dec 2018
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in impacted third molar (I3M) comparing Deflazacort with Placebo (2 arms). Primary endpoints: Postoperative Pain at 7 days, Postoperative Edema at 7 days and 1 more. Status: unknown.
02
Drugs
deflazacort
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on NCT04365088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04365088.